Cost of treatment in a US commercially insured, HIV-1-infected population
about
HIV Prevention: The Key to Ending AIDS by 2030.A Population-Based Study of Care at the End of Life Among People With HIV in Ontario From 2010 to 2013.48-week efficacy and safety of dolutegravir relative to commonly used third agents in treatment-naive HIV-1-infected patients: a systematic review and network meta-analysis.Cost and safety of assisted reproductive technologies for human immunodeficiency virus-1 discordant couples.Cost-Effectiveness of Single- Versus Generic Multiple-Tablet Regimens for Treatment of HIV-1 Infection in the United States.Addressing discriminatory benefit design for people living with HIV: a California case study.Quality of life of HIV-infected patients who switch antiretroviral medication due to side effects or other reasons.Healthcare Coverage for HIV Provider Visits Before and After Implementation of the Affordable Care Act.Healthcare utilization and direct costs of non-infectious comorbidities in HIV-infected patients in the USA.Clinical, economic, and humanistic burden of needlestick injuries in healthcare workers.The cost-effectiveness of oral HIV pre-exposure prophylaxis and early antiretroviral therapy in the presence of drug resistance among men who have sex with men in San Francisco.
P2860
Q30383177-32274C77-1F0F-43E4-A828-58BAAC5014D5Q33557825-B5E7F940-766A-43B4-BB8E-7BCD1D7B9706Q34134900-D5B0CE72-66D0-4924-8AA7-CE66BC2918C0Q35567815-C1C58F2A-8B7B-4307-A69D-8449C1B0D2A3Q35903617-5CC10EDB-DEE1-454B-9F16-D1A558222FCAQ38732649-9C039F20-5DF1-4A0C-BB04-FD374A3B976CQ40566104-3DB1EE6A-E41D-491C-A709-F35711F36BDAQ40770067-365A1130-FF1B-4F57-9F03-0927EC68834EQ41995759-8E013EBD-7D5A-4248-94D1-1ECBBA42B74DQ42370572-1F24FBA4-CBD1-4E70-BD75-1EB21C6B0DF7Q52567034-6E6113C4-3A8B-469B-8AF7-48943EB253D5
P2860
Cost of treatment in a US commercially insured, HIV-1-infected population
description
2014 nî lūn-bûn
@nan
2014 թուականին հրատարակուած գիտական յօդուած
@hyw
2014 թվականին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cost of treatment in a US commercially insured, HIV-1-infected population
@ast
Cost of treatment in a US commercially insured, HIV-1-infected population
@en
Cost of treatment in a US commercially insured, HIV-1-infected population
@nl
type
label
Cost of treatment in a US commercially insured, HIV-1-infected population
@ast
Cost of treatment in a US commercially insured, HIV-1-infected population
@en
Cost of treatment in a US commercially insured, HIV-1-infected population
@nl
prefLabel
Cost of treatment in a US commercially insured, HIV-1-infected population
@ast
Cost of treatment in a US commercially insured, HIV-1-infected population
@en
Cost of treatment in a US commercially insured, HIV-1-infected population
@nl
P2093
P2860
P3181
P1433
P1476
Cost of treatment in a US commercially insured, HIV-1-infected population
@en
P2093
Alexandra Khachatryan
Katherine Nedrow
Kit Simpson
Margaret Tawadrous
Richard Chambers
Seema Haider
Sonya J Snedecor
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0098152
P407
P577
2014-01-01T00:00:00Z